Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.41 |
| ▸ | DRD1 | P21728 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 2/20 | 0.41 |
| ▸ | HRH1 | P35367 | 2/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6430745 | 0.86 | JAK2 (0.39) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| SCHEMBL2478228 | 0.83 | LCK (0.48) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| SCHEMBL1306110 | 0.83 | JAK3 (0.45) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| SCHEMBL29591041 | 0.83 | JAK3 (0.45) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| SCHEMBL17961824 | 0.83 | DRD2 (0.36) | CYP2D6CYP2C19SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL27863544 | 0.81 | LCK (0.54) | CYP2D6CYP2C19JAK2JAK3SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4802990 | 0.81 | LCK (0.47) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| Hydrochloric Acid SCHEMBL4133640 | 0.81 | JAK3 (0.44) | CYP2D6CYP2C19JAK2JAK3SLC6A2 | |
| Hydrochloric Acid SCHEMBL30585784 | 0.80 | TRPM8 (0.40) | CYP2D6CYP2C19SMN1; SMN2LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL21641049 | 0.80 | TRPM8 (0.40) | CYP2D6CYP2C19SMN1; SMN2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8927534-B2 | Compounds for the inhibition of integrins and use thereof | SHIRE ORPHAN THERAPIES GMBH (DE) | 2015-01-06 | — | — | US | disclosed |
| US-20090104116-A1 | COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | JERINI AG (DE) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104116-A1 | COMPOUNDS FOR THE INHIBITION OF INTEGRINS AND USE THEREOF | ITGA1, ITGB1, ITGA5 | CYP2D6 3552/4885CYP2C19 3561/4885JAK2 557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.